Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection.

导出 LinkOut

翻译打印收藏纠错

作者： Cynthia L,Gay ^[1] ; Joann D,Kuruc ^[2] ; Shane D,Falcinelli ^[1] ; Joanna A,Warren ^[2] ; Sarah A,Reifeis ^[1] ; Jennifer L,Kirchherr ^[3] ; Katherine S,James ^[1] ; Morgan G,Dewey ^[3] ; Alyson,Helms ^[4] ; Brigitte,Allard ^[1] ; Erin,Stuelke ^[1] ; Alicia,Gamble ^[1] ; Ana,Plachco ^[1] ; Robert J,Gorelick ^[2] ; Joseph J,Eron ^[1] ; Michael,Hudgens ^[1] ; Carolina,Garrido ^[5] ; Nilu,Goonetilleke ^[5] ; Mark A,DeBenedette ^[6] ; Irina Y,Tcherepanova ^[1] ; Charles A,Nicolette ^[2] ; Nancie M,Archin ^[7] ; David M,Margolis ^[4]

作者单位： University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States. ^[1] Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States. ^[2] Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States. ^[3] Department of Biostatistics, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States. ^[4] Argos Therapeutics, Durham, North Carolina, USA. ^[5] AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States. ^[6] Department of Epidemiology, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States. ^[7] University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States. dmargo@med.unc.edu. ^[8] Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States. dmargo@med.unc.edu. ^[9] Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States. dmargo@med.unc.edu. ^[10] Department of Epidemiology, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States. dmargo@med.unc.edu. ^[11]